Serum N-glycomics for non-invasive detection of significant liver pathology across clinical phases of treatment-naïve chronic hepatitis B
Serum N-glycomics demonstrates promising potential for non-invasive identification of significant liver pathology in treatment-naïve CHB patients, providing an alternative approach for early treatment decisions, especially in ALT-normal patients with occult liver damage.
Authors
- Jinbao Huang
- Bo Han (ORCID: https://orcid.org/0000-0003-1458-4265)
- Tuo Shen (ORCID: https://orcid.org/0000-0002-4811-3309)
- X. J. Li
- Pengyuan Kang
- Meijie Shi
- Shanshan Ji
- Xiaoling Chi
- Yan Zhong
- Lei Xu
- Yuqi Zhang
- Cuiying Chen
- Chao Zhang
- Hao Yu
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Peking University (CN)
- Sichuan University (CN)
- Chizhou University (CN)
- West China Hospital of Sichuan University (CN)
- Guangdong Provincial Hospital of Traditional Chinese Medicine (CN)
- National Center for AIDS/STD Control and Prevention,China CDC (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2025-12-25
- DOI
- https://doi.org/10.1186/s12967-025-07455-6
- Primary Topic
- Glycosylation and Glycoproteins Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00